Reprints Desk solution will help the Medical Affairs group at Valeant Pharmaceuticals to securely acquire, manage and collaborate around scientific literature
Los Angeles, Calif., May 21, 2014 – Reprints Desk, Inc., a wholly-owned subsidiary of Research Solutions, Inc. (RSSS), today announced that Valeant Pharmaceuticals had adopted Bibliogo, the literature management and collaboration web application add-on for the company’s Article Galaxy software-as-a-service (SaaS) solution. Valeant Pharmaceuticals will utilize Bibliogo, winner of the 2012 Software & Information Industry (SIIA) CODiE Award for Best Online Science or Technology Service, to support drug safety monitoring and other literature-related medical affairs functions within the Latin America office.
“Bibliogo will help the Medical Affairs team at Valeant Pharmaceuticals to better acquire, manage and collaborate securely around the scientific literature that my team relies upon to support our internal and external customers,” said Gerardo Gutierrez, Scientific Librarian at Valeant Pharmaceuticals. “Bibliogo meets our specific needs for a collaborative, web-based reference management tool with permission schemas designed for use by corporations, complemented by additional functionality such as document delivery literature retrieval and integrated table of contents and saved search alerting.”
About Reprints Desk
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Organizations fueled by intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Reprints Desk has ranked #1 in the every Document Delivery Vendor Scorecard from industry analyst and advisory firm Outsell Inc. since 2008. Reprints Desk is a wholly owned subsidiary of Reseach Solutions, Inc. (RSSS).
Certain matters discussed in this press release may be forward-looking statements. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K and interim Quarterly Reports on Form 10-Q. Examples of forward-looking statements in this release include statements related the Company's products. The Company assumes no obligation to update the cautionary information in this release.